Literature DB >> 19416671

Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor.

A Savonenko1, P Munoz, T Melnikova, Q Wang, X Liang, R M Breyer, T J Montine, A Kirkwood, K Andreasson.   

Abstract

Cyclooxygenase-2 (COX-2) is a neuronal immediate early gene that is regulated by N-methyl d aspartate (NMDA) receptor activity. COX-2 enzymatic activity catalyzes the first committed step in prostaglandin synthesis. Recent studies demonstrate an emerging role for the downstream PGE(2) EP2 receptor in diverse models of activity-dependent synaptic plasticity and a significant function in models of neurological disease including cerebral ischemia, Familial Alzheimer's disease, and Familial amyotrophic lateral sclerosis. Little is known, however, about the normal function of the EP2 receptor in behavior and cognition. Here we report that deletion of the EP2 receptor leads to significant cognitive deficits in standard tests of fear and social memory. EP2-/- mice also demonstrated impaired prepulse inhibition (PPI) and heightened anxiety, but normal startle reactivity, exploratory behavior, and spatial reference memory. This complex behavioral phenotype of EP2-/- mice was associated with a deficit in long-term depression (LTD) in hippocampus. Our findings suggest that PGE(2) signaling via the EP2 receptors plays an important role in cognitive and emotional behaviors that recapitulate some aspects of human psychopathology related to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19416671      PMCID: PMC2720138          DOI: 10.1016/j.expneurol.2009.01.016

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  80 in total

Review 1.  Memory--a century of consolidation.

Authors:  J L McGaugh
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

2.  Associative memory formation increases the observation of dendritic spines in the hippocampus.

Authors:  Benedetta Leuner; Jacqueline Falduto; Tracey J Shors
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 3.  LTP and LTD: an embarrassment of riches.

Authors:  Robert C Malenka; Mark F Bear
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

4.  Paradoxical influence of hippocampal neurogenesis on working memory.

Authors:  Michael D Saxe; Gaël Malleret; Svetlana Vronskaya; Indira Mendez; A Denise Garcia; Michael V Sofroniew; Eric R Kandel; René Hen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

5.  Bidirectional trafficking of prostaglandin E2 receptors involved in long-term potentiation in visual cortex.

Authors:  Yukio Akaneya; Tadaharu Tsumoto
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

6.  Divergent effects of prostaglandin receptor signaling on neuronal survival.

Authors:  Liejun Wu; Qian Wang; Xibin Liang; Katrin Andreasson
Journal:  Neurosci Lett       Date:  2007-06-07       Impact factor: 3.046

7.  Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia.

Authors:  Jun Li; Xibin Liang; Qian Wang; Richard M Breyer; Louise McCullough; Katrin Andreasson
Journal:  Neurosci Lett       Date:  2008-04-20       Impact factor: 3.046

Review 8.  Prostaglandin and thromboxane biosynthesis.

Authors:  W L Smith; L J Marnett; D L DeWitt
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

9.  Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

Authors:  Louise McCullough; Liejun Wu; Norman Haughey; Xibin Liang; Tracey Hand; Qian Wang; Richard M Breyer; Katrin Andreasson
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

10.  Altered cortical synaptic morphology and impaired memory consolidation in forebrain- specific dominant-negative PAK transgenic mice.

Authors:  Mansuo L Hayashi; Se-Young Choi; B S Shankaranarayana Rao; Hae-Yoon Jung; Hey-Kyoung Lee; Dawei Zhang; Sumantra Chattarji; Alfredo Kirkwood; Susumu Tonegawa
Journal:  Neuron       Date:  2004-06-10       Impact factor: 17.173

View more
  32 in total

Review 1.  Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

Authors:  Susan B Powell; Martin Weber; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2012

2.  Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection.

Authors:  David T Stark; Nicolas G Bazan
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

Review 3.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

Authors:  Tony Wyss-Coray; Joseph Rogers
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 4.  Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.

Authors:  Andrew Schrepf; Susan K Lutgendorf; Leah M Pyter
Journal:  Brain Behav Immun       Date:  2015-05-06       Impact factor: 7.217

5.  Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury.

Authors:  Jianxiong Jiang; Ying Yu; Erika Reime Kinjo; Yifeng Du; Hoang Phuong Nguyen; Ray Dingledine
Journal:  Neuropharmacology       Date:  2019-02-11       Impact factor: 5.250

6.  PGE2 signaling via the neuronal EP2 receptor increases injury in a model of cerebral ischemia.

Authors:  Qingkun Liu; Xibin Liang; Qian Wang; Edward N Wilson; Rachel Lam; Jing Wang; William Kong; Connie Tsai; Tingting Pan; Paul B Larkin; Mehrdad Shamloo; Katrin I Andreasson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

Review 7.  Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.

Authors:  Eiron Cudaback; Nikolas L Jorstad; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Biochem Pharmacol       Date:  2014-01-13       Impact factor: 5.858

Review 8.  The endocannabinoid system as a target for novel anxiolytic drugs.

Authors:  Sachin Patel; Mathew N Hill; Joseph F Cheer; Carsten T Wotjak; Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

9.  Inhibiting the PGE2 Receptor EP2 Mitigates Excitotoxicity and Ischemic Injury.

Authors:  Lexiao Li; Ying Yu; Ruida Hou; Jiukuan Hao; Jianxiong Jiang
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-25

10.  Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease.

Authors:  Patrick J Cimino; Yue Yang; Xianwu Li; Jake F Hemingway; Makenzie K Cherne; Shawn B Khademi; Yoshinori Fukui; Kathleen S Montine; Thomas J Montine; C Dirk Keene
Journal:  Exp Mol Pathol       Date:  2013-01-11       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.